StockData
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. (MRKR) shareholders

MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.84+0.01 (+0.97%)

Close on Nov 17, 2026Market cap $13.95MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
23.8%
4M of 17M shares
Institutional holders
35
4 new, 4 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Carmen Chang
Joint filing with New Enterprise Associates 16, L.P. (9.90%), NEA Partners 16, L.P. (9.90%) and 7 more
1,670,0819.90%13D (active) amendmentNov 13, 2025
New Enterprise Associates 16, L.P.
Joint filing with NEA Partners 16, L.P. (15.20%), Nea 16 Gp, LLC (15.20%) and 7 more
1,625,67815.20%13D (active) amendmentDec 19, 2024
Alyeska Investment Group, L.P.
Joint filing with Alyeska Fund GP, LLC (9.90%), Anand Parekh (9.90%)
1,280,9529.90%13G (passive) amendmentSep 30, 2025
Blue Owl Capital Holdings LP1,127,0529.99%13G (passive) amendmentMar 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MRKRValueChange% of portfolio
NEA Management Company, LLC1,625,6789.75%$2.39M–0.15%
Blue Owl Capital Holdings LP554,2503.32%$814.75K–0.12%
Vanguard Capital Management LLC426,1692.56%$626.47K+36,8500.00%
Aisling Capital Management LP325,3701.95%$478.29K–0.10%
Renaissance Technologies LLC249,4231.50%$366.65K+74,1290.00%
Geode Capital Management, LLC139,8160.84%$205.56K−21,0940.00%
Osaic Holdings, Inc.112,6490.68%$165.59K+19,5280.00%
Vanguard Fiduciary Trust Co87,2690.52%$128.29K–0.00%
LPL Financial LLC83,1470.50%$122.23K+1000.00%
Concurrent Investment Advisors, LLC67,9630.41%$99.91KNew0.00%
Two Sigma Investments, LP60,2010.36%$88.50K−8000.00%
XTX Topco Ltd45,3570.27%$66.68K−18,2100.00%
Northern Trust Corp34,6290.21%$50.91K+8,6200.00%
Citadel Advisors LLC32,5170.20%$47.80KNew0.00%
State Street Corp20,9480.13%$30.79K–0.00%
Invst, LLC18,0000.11%$26.46K−11,0000.00%
Creative Planning17,3120.10%$25.45K–0.00%
Jane Street Group, LLC16,8320.10%$24.74K−19,4710.00%
Ashton Thomas Private Wealth, LLC16,4000.10%$24.11K–0.00%
Virtu Financial LLC11,5740.07%$17.00KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026354M23.8%4 / 67 / 40M0M
Q1 2026354M23.4%7 / 68 / 71M0M
Q4 2025364M24.3%9 / 104 / 51M0M
Q3 2025323M20.7%8 / 93 / 70M0M
Q2 2025313M20.5%3 / 76 / 40M1M
Q1 2025324M24.6%3 / 106 / 30M1M
Q4 2024334M26.8%8 / 85 / 33M0M
Q3 2024282M12.1%5 / 53 / 40M0M
Q2 2024282M12.0%2 / 84 / 20M0M
Q1 2024282M11.9%3 / 86 / 10M0M
Q4 2023262M11.9%0 / 65 / 20M0M
Q3 2023282M11.6%1 / 97 / 20M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

6 funds held MRKR in Q2 2026, 77% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of MRKRValue% of fundAs of
Vanguard Total Stock Market Index Fund298,0931.79%$438.20K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund128,0760.77%$188.27K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund88,0240.53%$138.20K0.00%May 31, 2026
Fidelity Series Total Market Index Fund19,3880.12%$30.44K0.00%May 31, 2026
Fidelity Total Market Index Fund12,8110.08%$20.11K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund5,2720.03%$8.28K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Juan VeraChief Executive Officer, Director2,671,84516.02%Nov 4, 2025
Norman David EansorDirector9,5700.06%Nov 19, 2025
Steve ElmsDirector328,3381.97%Nov 19, 2025
Katharine KnobilDirector1,5000.01%Nov 19, 2025
Kathryn Penkus CorzoDirector––Nov 4, 2025
Ali Behbahani10% owner10,714,28564.26%Dec 23, 2024
NEA Partners 16, L.P.10% owner1,625,6789.75%Dec 23, 2024
Nea 16 Gp, Llc10% owner––Dec 23, 2024
Carmen Chang10% owner10,714,28564.26%Dec 23, 2024
Paul Edward Walker10% owner10,714,28564.26%Dec 23, 2024
New Enterprise Associates 16, L.P.10% owner––Dec 23, 2024
Mohamad Makhzoumi10% owner10,714,28564.26%Dec 23, 2024
Scott D. Sandell10% owner10,714,28564.26%Dec 23, 2024
Anthony A. Florence Jr.10% owner10,714,28564.26%Dec 23, 2024
Forest Baskett10% owner10,714,28564.26%Dec 23, 2024

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Steve Elms
Director
Dec 23, 2024Buy+11,085$3.20$35.47K325,370
NEA Partners 16, L.P.
10% owner
Dec 23, 2024Buy+554,250$3.20$1.77M1,625,678
Anthony H. Kim
Chief Financial Officer
Mar 24, 2022Tax withholding−36,076$0.48$17.32K114,436
Anthony H. Kim
Chief Financial Officer
Mar 24, 2022Award+150,512––150,512
Peter L. Hoang
President and CEO, Director
Mar 24, 2022Tax withholding−48,376$0.48$23.22K483,286
Peter L. Hoang
President and CEO, Director
Mar 24, 2022Award+199,094––531,662
Juan Vera
Chief Scientific Officer & COO, Director
Mar 24, 2022Tax withholding−33,465$0.48$16.06K2,671,845
Juan Vera
Chief Scientific Officer & COO, Director
Mar 24, 2022Award+140,823––2,705,310
Frederick Gerald Wasserman
Director
Jun 8, 2021Award+12,658––65,223
John Robert Wilson
Director
Jun 8, 2021Award+12,658––7,812,008
Steve Elms
Director
Jun 8, 2021Award+12,658––29,680
Norman David Eansor
Director
Jun 8, 2021Award+12,658––36,940
David Laskow-Pooley
Director
Jun 8, 2021Award+12,658––55,223
Frederick Gerald Wasserman
Director
May 18, 2021Buy+10,000$2.41$24.10K52,565
Norman David Eansor
Director
Mar 25, 2021Gift+7,142––7,142
Norman David Eansor
Director
Mar 25, 2021Gift−14,285––2,428
Norman David Eansor
Director
Mar 25, 2021Gift+7,142––7,142
Norman David Eansor
Director
Mar 16, 2021Buy+14,285$17.50$249.99K16,713
Mohamad Makhzoumi
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
Forest Baskett
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
Paul Edward Walker
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
NEA Partners 16, L.P.
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
Ali Behbahani
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
Carmen Chang
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
Peter L. Hoang
President and CEO, Director
Mar 16, 2021Buy+142,857$1.75$250.00K332,568
Joshua Makower
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
Scott D. Sandell
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
Anthony A. Florence Jr.
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
Steve Elms
Director
Mar 16, 2021Buy+1,142,857$1.75$2.00M3,142,857
Juan Vera
Chief Development Officer
Mar 16, 2021Buy+571,428$1.75$1,000.00K2,564,487
Peter W. Sonsini
10% owner
Mar 16, 2021Buy+5,714,285$1.75$10.00M10,714,285
John Robert Wilson
Director
Mar 16, 2021Buy+1,714,285$1.75$3.00M7,799,350
Steve Elms
Director
May 19, 2020Award+17,022––17,022
David Laskow-Pooley
Director
May 19, 2020Award+17,022––42,565
Frederick Gerald Wasserman
Director
May 19, 2020Award+17,022––42,565
John Robert Wilson
Director
May 19, 2020Award+17,022––6,085,065
Norman David Eansor
Director
May 19, 2020Award+17,022––24,282
Kenneth Bryan Dart
10% owner
Feb 18, 2020Option exercise+416,667$1.20$500.00K4,050,001
Peter L. Hoang
President and CEO, Director
Aug 14, 2019Buy+10,000$4.62$46.20K189,711
Frederick Gerald Wasserman
Director
May 9, 2019Award+7,260––25,543
Norman David Eansor
Director
May 9, 2019Award+7,260––7,260
David Laskow-Pooley
Director
May 9, 2019Award+7,260––25,543
John Robert Wilson
Director
May 9, 2019Award+7,260––6,068,043
David Laskow-Pooley
Director
Oct 16, 2018Award+5,168––18,283
Frederick Gerald Wasserman
Director
Oct 16, 2018Award+5,168––18,283
Joshua Silverman
Director
Oct 16, 2018Award+4,106––17,221
Sherry Grisewood
Director
Oct 16, 2018Award+4,106––19,582
Mark Reddish
Director
Oct 16, 2018Award+4,106––36,110
Glynn Wilson
Director
Oct 9, 2018Tax withholding−7,561––181,776
Glynn Wilson
Director
Oct 9, 2018Award+31,120––189,337
Kenneth Bryan Dart
10% owner
May 14, 2018Buy+1,300,000$2.40$3.12M5,300,002
Joshua Silverman
Director
Feb 28, 2018Other+153,333––153,333
Glynn Wilson
Director
Sep 22, 2017Award+100,000$3.18$318.00K185,567
Glynn Wilson
Director
Sep 22, 2017Tax withholding−27,350$3.18$86.97K158,217
Peter L. Hoang
CEO and President, Director
Sep 22, 2017Tax withholding−70,289$3.18$223.52K179,711
Peter L. Hoang
CEO and President, Director
Sep 22, 2017Award+250,000$3.18$795.00K250,000
Mark Reddish
Director
Aug 29, 2017Award+13,115––32,004
Joshua Silverman
Director
Aug 29, 2017Award+13,115––13,115
David Laskow-Pooley
Director
Aug 29, 2017Award+13,115––13,115
Sherry Grisewood
Director
Aug 29, 2017Award+13,115––15,476

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
1.55%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+61.4%
From 0M shares
Short volume, 20 days
42.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Marker Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,052 shares on Oct 8, 2026 over the last 90 days.

See a number that looks wrong?